Paper - WANFANG MED ONLINE

You Position: Home > Paper

Radiofrequency ablation of hepatocellular carcinoma:Prognostic factors and recent advances

( views:13, downloads:0 )

Author:: No author available

Journal Title:: World Chinese Journal of Digestology

Issue:: 13

DOI:: 10.11569/wcjd.v29.i13.677

Key Word:: 原发性肝细胞癌;射频消融;预测模型;预后因素

Abstract：随着医学诊疗水平的提高,射频消融在治疗原发性肝癌的临床应用和基础研究方面都取得飞速进展发挥着越来越重要的作用:(1)射频消融治疗原发性肝癌的10年总生存率为27.3％-46.1％,对于肿瘤单发且最大径≤3 cm的HCC患者,10年总生存率可达74％,生存结果与手术切除相似;(2)射频消融联合其他治疗等可以扩大消融治疗的适应证,使患者生存获益;(3)建立预测射频消融治疗原发性肝癌的预后模型,可指导制定治疗和随访策略,为临床个体化诊疗提供重要依据.

Reference

[1]郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].2019,(1).
[2]Elliot B, Tapper,Neehar D, Parikh.Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.[J].2018,362(Spec ).
[3]Doyle, Adam,Gorgen, Andre,Muaddi, Hala,etc.Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients[J].2019,70(5).
[4]Chang Gon Kim,Hyun Woong Lee,Hye Jin Choi,etc.Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation[J].2019,8(11).
[5]Nault, Jean-Charles,Sutter, Olivier,Nahon, Pierre,etc.Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations[J].2018,68(4).
[6]Wei-Yu, Kao,Chien-Wei, Su,Yi-You, Chiou,etc.Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation.[J].2017,(Spec ).
[7]Laura Kulik,Julie K. Heimbach,Feras Zaiem,etc.Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis[J].2018,67(1).
[8]Min, J. H.,Kang, T. W.,Cha, D., I,etc.Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes[J].2018,73(7).
[9]Sugimoto, Katsutoshi,Kakimi, Kazuhiro,Takeuchi, Hirohito,etc.Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma[J].2019,30(6).
[10]Erstad Derek J.,Tanabe Kenneth K..Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma[J].2019,26(5).
[11]Wei Yang,Kun Yan,S Nahum Goldberg,etc.Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment[J].2016,(10).
[12]Sato,T.,Goto,T.,Arano,T.,etc.Radiofrequency ablation for hepatocellular carcinoma: 10-Year outcome and prognostic factors[J].2012,107(4).
[13].Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients.[J].2019,14(1).
[14]Lee, Hyo-jae,Kim, Jin Woong,Hur, Young Hoe,etc.Combined Therapy of Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Surgical Resection for Single 2-3 cm Hepatocellular Carcinoma: A Propensity-Score Matching Analysis[J].2017,28(9).
[15].Trans-arterial chemoembolization plus radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis[J].2020,46(5).
[16]Yoshitaka Takuma,Iwadou Shota,Hirokazu Miyatake,etc.Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma[J].2018,57(4).
[17]Shunli, Shen,Hong, Peng,Ye, Wang,etc.Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis.[J].2018,18(1).
[18]Donghee Kim,Andrew A. Li,Brandon J. Perumpail,etc.Changing Trends in Etiology‐Based and Ethnicity‐Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States[J].2019,69(3).
[19]Xia, Yong,Li, Jun,Liu, Guanghua,etc.Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma A Randomized Clinical Trial[J].2020,6(2).
[20]Lee Min Woo,Kang Danbee,Lim Hyo Keun,etc.Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival[J].2020,30(4).
[21]Eunae,Cho,Hyun A,Cho,Chung Hwan,Jun,etc.A Review of Hepatocellular Carcinoma in Elderly Patients Focused on Management and Outcomes.[J].2020,33(5).
[22]Llovet Josep M.,Kelley Robin Kate,Villanueva Augusto,etc.Hepatocellular carcinoma[J].2021,7(1).
[23].Radiofrequency ablation versus laparoscopic hepatectomy for hepatocellular carcinoma: A real world single center study[J].2020,46(4 Pt.A).
[24]Poon Ronnie Tung-Ping,Fan Sheung-Tat,Lo Chung-Mau,etc.Intrahepatic Recurrence After Curative Resection of Hepatocellular Carcinoma[J].1999.
[25]M Shimada,K Takenaka,T Gion,etc.Prognosis of recurrent hepatocellular carcinoma: A 10-year surgical experience in Japan[J].1996,111(3).
[26]Hongmei Zeng,Wanqing Chen,Rongshou Zheng,etc.Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J].2018,6(5).
[27]Rhim, Hyunchul,Lee, Sunyoung,Kang, Tae Wook,etc.Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes[J].2018,69(1).
[28]Donna L. White,Aaron P. Thrift,Fasiha Kanwal,etc.Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012[J].2016,152(4).
[29]Fukuda,H.,Numata,K.,Moriya,S.,etc.Hepatocellular carcinoma: Concomitant sorafenib promotes necrosis after radiofrequency ablation - Propensity score matching analysis[J].2014,272(2).
[30]Chu, Hee Ho,Kim, Jin Hyoung,Yoon, Hyun-Ki,etc.Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis[J].2019,30(10).
[31]Feng,K.,Yan,J.,Li,X.,etc.A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J].2012,57(4).
[32]Won, Sohn,Tae Wook, Kang,Sun-Kyu, Choi,etc.Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma.[J].2016,(30).
[33]Rajyaguru, Devalkumar J.,Borgert, Andrew J.,Smith, Angela L.,etc.Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database[J].2018,36(6).
[34]Jiang, Xiong-ying,Xu, Lin-feng,Ni, Jia-yan,etc.Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization Therapy Versus Surgical Resection for Hepatocellular Carcinoma within the Milan Criteria: A Meta-Analysis[J].2018,19(4).
[35]Kanwal, Fasiha,Singal, Amit G..Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction[J].2019,157(1).
[36]Tao, Pan,Lu-Wen, Mu,Chun, Wu,etc.Comparison of Combined Transcatheter Arterial Chemoembolization and CT-guided Radiofrequency Ablation with Surgical Resection in Patients with Hepatocellular Carcinoma within the Up-to-seven Criteria: A Multicenter Case-matched Study.[J].2017,8(17).
[37]K. K. C. Ng,K. S. H. Chok,A. C. Y. Chan,etc.Randomized clinical trial of hepatic resection versus radiofrequency ablation for early‐stage hepatocellular carcinoma[J].2017,104(13).
[38]Chen,M.-S.,Shi,M.,Peng,Z.-W.,etc.Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: A retrospective comparative study[J].2012,262(3).
[39]Min Woo Lee,Steven S. Raman,Nazanin H. Asvadi,etc.Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10‐year intention‐to‐treat analysis[J].2017,65(6).
[40]Hae Won, Lee,Jeong Min, Lee,Jung-Hwan, Yoon,etc.A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma.[J].2018,94(2).
[41]Freddie Bray,Jacques Ferlay,Isabelle Soerjomataram,etc.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].2018,68(6).
[42]Lee, Seohyun,Han, Seungbong,Shim, Ju Hyun,etc.A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma[J].2015,26(12).
[43]Ding Min,Zhao Xiaodong,Zhao Mingchen,etc.Prognostic Nomogram for Patients with Hepatocellular Carcinoma After Thermal Ablation[J].2020,43(11).
[44]Wencheng,Tan,Qiwen,Deng,Shiyong,Lin,etc.Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.[J].2019,36(1).
[45]Uhlig Johannes,Sellers Cortlandt M.,Stein Stacey M.,etc.Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database[J].2018,29(5).
[46][Noauthornameavailable].EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].2012,56(4).
[47]Jin Shan,Tan Shisheng,Peng Wen,etc.Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysis[J].2020,18(1).
[48]Lei,Zheng,Chi-Hao,Zhang,Jia-Yun,Lin,etc.Comparative Effectiveness of Radiofrequency Ablation vs. Surgical Resection for Patients With Solitary Hepatocellular Carcinoma Smaller Than 5 cm.[J].2020,10.
[49]Gregory C. Wilson,David A. Geller.Evolving Surgical Options for Hepatocellular Carcinoma[J].2019,28(4).
[50]Lee, Dong Ho,Lee, Jeong Min,Kang, Tae Wook,etc.Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study[J].2018,286(1).
[51]Song, Kyoung Doo,Lim, Hyo Keun,Rhim, Hyunchul,etc.Repeated Hepatic Resection versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Hepatic Resection: A Propensity Score Matching Study[J].2015,275(2).
[52]Pompili,M.,Saviano,A.,DeMatthaeis,N.,etc.Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey[J].2013,59(1).
[53]Xiaocheng Li,"ORCID":"http:\/\/orcid.org\/0000-0002-6122-2593Yu-Shen Wu,Duke Chen,etc.Laparoscopic hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis[J].2019,11.
[54]Matteo Renzulli,Francesco Tovoli,Alfredo Clemente,etc.Ablation for hepatocellular carcinoma: beyond the standard indications[J].2020,37(4).